Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000927016-03-001027
Filing Date
2003-03-10
Accepted
2003-03-10 17:21:42
Documents
1
Group Members
EDWARD K. CHANDLERGRAYSTONE VENTURE PARTNERS, LLCJUDITH BULTMAN MEYER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 78193
  Complete submission text file 0000927016-03-001027.txt   80341
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Subject) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46114 | Film No.: 03598524
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address
Business Address ONE NORTHFIELD PLAZA SUITE 530 NORTHFIELD IL 60093 8474469460
GRAYSTONE VENTURE DIRECT EQUITY LP (Filed by) CIK: 0001219798 (see all company filings)

EIN.: 364132982 | State of Incorp.: DE | Fiscal Year End: 1231